The importance of performing liquid biopsies and detecting circulating tumor cells (CTCs) in NSCLC is crucial for identifying activating genetic mutations, such as ALK (anaplastic lymphoma kinase) rearrangements. This evidence concerns the gene ALK and non-small cell lung carcinoma.